Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |